Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference?
- PMID: 1565754
- DOI: 10.1097/00006842-199203000-00004
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference?
Abstract
Five degree of change criteria used in previous research to confirm premenstrual syndrome/late luteal phase dysphoric disorder (PMS/LLPDD) based on daily ratings were examined to determine how well each differentiated between women claiming to experience severe symptoms and women with normal menstrual experience. Frequency and nature of stressful events and subjective perceptions of impairment were also examined. Ratings were evaluated in 31 women who met DSM III-R criteria for a provisional diagnosis of LLPDD, and 34 women who reported no premenstrual symptomatology. Ratings for a sample of women taking oral contraceptives and a sample of men were also included for comparison purposes. Results indicated no differences between the groups in the frequency of stressful events. However, the PMS/LLPDD group rated their problems as more disturbing and evidenced a cyclical pattern in the occurrence of negative interpersonal interactions at work that was suggestive of some impaired functioning. None of the five change criteria differentiated the PMS/LLPDD group from the normally cycling No PMS group, and only one differentiated this group from the oral contraceptive No PMS group. This was true whether a liberal or conservative standard of confirmation was applied. The implications of these findings for using daily ratings to confirm PMS/LLPDD are discussed.
Comment in
-
Late luteal phase dysphoric disorder.Psychosom Med. 1992 Nov-Dec;54(6):723-8. doi: 10.1097/00006842-199211000-00012. Psychosom Med. 1992. PMID: 1454966 No abstract available.
Similar articles
-
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations.Psychosom Med. 1992 Mar-Apr;54(2):149-66. doi: 10.1097/00006842-199203000-00003. Psychosom Med. 1992. PMID: 1565753 Clinical Trial.
-
High nocturnal body temperature in premenstrual syndrome and late luteal phase dysphoric disorder.Am J Psychiatry. 1991 Oct;148(10):1329-35. doi: 10.1176/ajp.148.10.1329. Am J Psychiatry. 1991. PMID: 1897612
-
Daily symptom ratings for studying premenstrual dysphoric disorder: A review.J Affect Disord. 2016 Jan 1;189:43-53. doi: 10.1016/j.jad.2015.08.063. Epub 2015 Sep 14. J Affect Disord. 2016. PMID: 26406968 Review.
-
Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints.Am J Psychiatry. 1992 Apr;149(4):525-30. doi: 10.1176/ajp.149.4.525. Am J Psychiatry. 1992. PMID: 1554039
-
Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:25-37. doi: 10.1016/s0306-4530(03)00099-4. Psychoneuroendocrinology. 2003. PMID: 12892988 Review.
Cited by
-
Premenstrual symptoms in young adults born preterm at very low birth weight--from the Helsinki Study of Very Low Birth Weight Adults.BMC Womens Health. 2011 Jun 3;11:25. doi: 10.1186/1472-6874-11-25. BMC Womens Health. 2011. PMID: 21639914 Free PMC article.
-
Premenstrual dysphoric disorder: burden of illness and treatment update.J Psychiatry Neurosci. 2008 Jul;33(4):291-301. J Psychiatry Neurosci. 2008. PMID: 18592027 Free PMC article.
-
The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.CNS Drugs. 2010 Mar;24(3):207-25. doi: 10.2165/11530120-000000000-00000. CNS Drugs. 2010. PMID: 20155996 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous